Fragment-based Drug Discovery Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Fragment-based Drug Discovery Market estimated at US$568 Million in the year 2020 and it is projected to reach a revised size of US$1.1 Billion by 2028, growing at a CAGR of 10% over the period 2022-2028.

Fragment-based drug discovery is used to find similar compounds, such as lead, in a drug discovery process that is based on the identification of chemical fragments, which can become biological targets or can be combined to generate lead molecules. The introduction of new technologies into existing fragment-based drug discovery practices has resulted in significant time and cost savings, increasing the demand for these practices. Combinatorial chemistry and high-throughput screening are some of the recently adopted practices that have helped make fragment-based drug discovery programs much faster and cheaper than ever before.

Market Segments

By Technology/Service/Component

• Fragment Screening
• Non-Biophysical Techniques

By End User

• Academic and Research Institutions
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)

Key Players

• Astex Pharmaceuticals, Inc,
• Alveus Pharmaceuticals Pvt. Ltd.
• Beactica Therapeutics AB
• Charles River Laboratories, Inc.
• Crown Bioscience, Inc.
• Emerald BioStructures, Inc. / deCODE biostructures, Inc (deCODE genetics)
• Evotec A.G. (Evotec SE)
• Kinetic Discovery Ltd.
• Proteros biostructures GmbH
• Sprint Bioscience AB
• Structure Based Design, Inc.
• Sygnature Discovery

Scope of the Report

The research study analyzes the global Fragment-based Drug Discovery industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Fragment-based Drug Discovery Market Report

1. What was the Fragment-based Drug Discovery Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Fragment-based Drug Discovery Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Fragment-based Drug Discovery Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.